Despite all of the advances in medicine over the past 40 years, clinical trials remain complicated and arduous. The output of this research is often unstructured and difficult to analyze, aggregate, or incorporate in new clinical research projects.
We are reimagining how clinical trials are researched and planned by removing the barriers between data and end-users. We do this by mining massive amounts of trial related documents from both customers and the public domain— so you don’t have to.
The Trials.ai platform leverages state of the art, artificial intelligence to optimize clinical trial protocols for speed and success.
Optimize clinical trial protocols for speed and success with insights and recommendations for…
The system cross-compares data across all therapeutic areas from past trials, medical journals, thought leaders, clinical, regulatory agencies and other trial-related documents to find similarities, provide recommendations and points of interest.
Think of Trials.ai as the best second opinion you’ve ever had. The result is an optimized trial that ultimately enables a new treatment to reach patients faster— all through the lens of time, cost, and patient centricity powered by our Patient Burden Index™.
Our system also looks for potential pitfalls that might need to be flagged and adjusted. Get feedback about how each decision you make affects:
Read latest paper published by our Chief Scientist, David Fogel Ph.D, in Contemporary Clinical Trials Communications.Read it